OrbiMed Genesis GP LLC (CIK 0001808744)

Latest company ownership

Shares held
7,663,349
Last filed at
May 20, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q2 2025Q4
Shares held
6,475,291
Last filed at
Nov 24, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
3,571,428
Last filed at
Nov 8, 2021
Confidence Score
48.4
2025Q4
Confidence Score History
2021Q4 2025Q4
Shares held
3,073,298
Last filed at
Sep 2, 2025
Confidence Score
59.4
2025Q4
Confidence Score History
2025Q3 2025Q4
ACET - Adicet Bio, Inc.
Role: 10% Owner
Shares held
2,930,527
Last filed at
Oct 10, 2025
Confidence Score
87.5
2025Q4
Confidence Score History
2023Q2 2025Q4
IMA - ImageneBio, Inc.
Role: Director
Shares held
2,346,399
Last filed at
Sep 21, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
GLTO - Galecto, Inc.
Role: 10% Owner
Shares held
1,510,375
Last filed at
Aug 17, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
755,635
Last filed at
Jul 17, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q3 2025Q4
Shares held
747,887
Last filed at
Feb 19, 2025
Confidence Score
50.5
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
443,792
Last filed at
Apr 4, 2025
Confidence Score
52.1
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
252,858
Last filed at
Aug 15, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
Shares held
231,098
Last filed at
Dec 30, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
186,541
Last filed at
Mar 26, 2025
Confidence Score
49.4
2025Q4
Confidence Score History
2023Q1 2025Q4
Shares held
119,522
Last filed at
Aug 15, 2024
Confidence Score
25.6
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 21, 2025 Dec 18, 2025 Keros Therapeutics, Inc. Director Sell 17.5 -214,522 -21.06% ✗ $3.8M
Oct 8, 2025 Oct 10, 2025 Adicet Bio, Inc. 10% Owner Buy 100.0 +5,000,000 58.71% ✗ $5M
Aug 25, 2025 Sep 2, 2025 Shattuck Labs, Inc. Director Buy 100.0 +6,306,127 100.00% ✗ $5.5M
Apr 9, 2025 Apr 11, 2025 Compass Therapeutics, Inc. Director Sell 16.3 -3,571,428 -100.00% ✗ $5.7M
Apr 3, 2025 Apr 4, 2025 Edgewise Therapeutics, Inc. Director Buy 95.0 +496,771 3.37% ✗ $10M
Mar 24, 2025 Mar 26, 2025 Disc Medicine, Inc. Director Sell 37.5 -5,738 -0.40% ✗ $310.5K
Mar 19, 2025 Mar 21, 2025 Disc Medicine, Inc. Director Sell 17.5 -52,429 -1.21% ✗ $2.8M
Mar 10, 2025 Mar 12, 2025 Disc Medicine, Inc. Director Sell 15.0 -312,384 -3.87% ✗ $17M
Feb 14, 2025 Feb 19, 2025 MBX Biosciences, Inc. Director Buy 87.5 +190,672 1.87% ✗ $2M
Sep 16, 2024 Sep 17, 2024 MBX Biosciences, Inc. Director Buy 100.0 +750,000 24.49% ✗ $12M
Aug 13, 2024 Aug 15, 2024 Keros Therapeutics, Inc. Director Sell 15.0 -250,000 -19.70% ✗ $11M
Aug 13, 2024 Aug 15, 2024 scPharmaceuticals Inc. 10% Owner Buy 95.0 +500,000 8.99% ✗ $2M
Jul 15, 2024 Jul 17, 2024 Terns Pharmaceuticals, Inc. Director Sell 37.5 -56,164 -0.37% ✗ $561.6K
Jun 17, 2024 Jun 20, 2024 Disc Medicine, Inc. Director Buy 92.5 +83,334 4.90% ✗ $3M
May 16, 2024 May 20, 2024 Enliven Therapeutics, Inc. Director Sell 15.0 -1,033,300 -11.54% ✗ $22.9M
Jan 25, 2024 Jan 26, 2024 Adicet Bio, Inc. Director Buy 100.0 +3,125,000 47.01% ✗ $7.5M
Jan 23, 2024 Jan 25, 2024 Edgewise Therapeutics, Inc. Director Buy 92.5 +454,545 3.25% ✗ $5M
Dec 18, 2023 Dec 20, 2023 Disc Medicine, Inc. Director Sell 47.5 -1,724 -0.10% ✗ $102.1K
Dec 14, 2023 Dec 15, 2023 Disc Medicine, Inc. Director Sell 15.0 -433,200 -20.29% ✗ $24.6M
Dec 12, 2023 Dec 14, 2023 Disc Medicine, Inc. Director Sell 16.3 -134,200 -2.11% ✗ $7.9M
Nov 22, 2023 Nov 24, 2023 PMV Pharmaceuticals, Inc. 10% Owner Sell 22.5 -87,786 -100.00% ✗ $195.8K
Aug 15, 2023 Aug 17, 2023 Galecto, Inc. 10% Owner Sell 20.0 -822,680 -26.87% ✗ $617K
Jul 31, 2023 Aug 2, 2023 Galecto, Inc. 10% Owner Sell 20.0 -209,400 -6.29% ✗ $628.2K
Jul 25, 2023 Jul 27, 2023 Galecto, Inc. 10% Owner Sell 22.5 -39,200 -1.16% ✗ $114.5K
Jul 13, 2023 Jul 17, 2023 Galecto, Inc. 10% Owner Sell 20.0 -194,700 -5.46% ✗ $467.3K
Jun 27, 2023 Jun 29, 2023 Adicet Bio, Inc. Director Buy 100.0 +875,000 12.10% ✗ $1.8M
Apr 13, 2023 Apr 17, 2023 Galecto, Inc. 10% Owner Sell 32.5 -68,481 -0.63% ✗ $128.3K
Apr 10, 2023 Apr 12, 2023 Galecto, Inc. 10% Owner Sell 32.5 -67,537 -0.61% ✗ $121.4K
Apr 5, 2023 Apr 7, 2023 Galecto, Inc. 10% Owner Sell 22.5 -102,630 -1.37% ✗ $222K
Feb 15, 2023 Feb 17, 2023 Disc Medicine, Inc. Director Buy 95.0 +108,696 5.03% ✗ $2.5M
Dec 23, 2022 Dec 28, 2022 Terns Pharmaceuticals, Inc. Director Buy 90.0 +137,931 2.91% ✗ $1000K
Nov 25, 2022 Nov 29, 2022 scPharmaceuticals Inc. 10% Owner Buy 100.0 +762,380 16.70% ✗ $4M
Nov 8, 2022 Nov 10, 2022 Compass Therapeutics, Inc. Director Buy 92.5 +402,000 2.71% ✗ $1.3M
Sep 16, 2022 Sep 16, 2022 Edgewise Therapeutics, Inc. Director Buy 92.5 +484,496 3.59% ✗ $5M
Aug 16, 2022 Aug 18, 2022 Terns Pharmaceuticals, Inc. Director Buy 100.0 +3,690,000 97.33% ✗ $8.9M
Jun 22, 2022 Jun 24, 2022 ImageneBio, Inc. Director Sell 17.5 -252,225 -1.83% ✗ $1.1M
May 26, 2022 May 31, 2022 PMV Pharmaceuticals, Inc. 10% Owner Sell 20.0 -26,253 -23.02% ✗ $418.2K
May 18, 2022 May 20, 2022 Edgewise Therapeutics, Inc. Director Buy 85.0 +138,000 1.03% ✗ $995K
May 11, 2022 May 13, 2022 Compass Therapeutics, Inc. Director Buy 85.0 +192,516 1.32% ✗ $420.5K
May 6, 2022 May 10, 2022 Compass Therapeutics, Inc. Director Buy 72.5 +125,359 0.86% ✗ $197.3K
Mar 29, 2022 Mar 31, 2022 PMV Pharmaceuticals, Inc. 10% Owner Sell 15.0 -474,500 -100.00% ✗ $10.3M
Dec 29, 2021 Dec 30, 2021 Janux Therapeutics, Inc. Director Sell 20.0 -40,400 -1.60% ✗ $820.1K
Dec 21, 2021 Dec 23, 2021 Janux Therapeutics, Inc. Director Sell 17.5 -119,400 -4.51% ✗ $2.3M
Dec 16, 2021 Dec 17, 2021 Janux Therapeutics, Inc. Director Sell 16.3 -393,300 -12.93% ✗ $7.5M
Nov 4, 2021 Nov 8, 2021 Compass Therapeutics, Inc. Director Buy 100.0 +5,357,143 42.13% ✗ $18.8M
Jun 15, 2021 Jun 16, 2021 Janux Therapeutics, Inc. Director Buy 100.0 +705,853 30.20% ✗ $12M
Mar 30, 2021 Apr 13, 2021 ImageneBio, Inc. Director Buy 100.0 +423,400 27.98% ✗ $6.8M
Mar 30, 2021 Apr 1, 2021 ImageneBio, Inc. Director Buy 100.0 +423,400 22.46% ✗ $6.8M
Mar 30, 2021 Mar 31, 2021 Edgewise Therapeutics, Inc. Director Buy 93.8 +359,375 2.70% ✗ $5.8M
Nov 2, 2020 Nov 4, 2020 Galecto, Inc. Director Buy 100.0 +733,333 25.48% ✗ $11M
Sep 25, 2020 Sep 29, 2020 PMV Pharmaceuticals, Inc. Director Buy 100.0 +950,000 100.00% ✗ $17.1M
May 21, 2020 May 26, 2020 scPharmaceuticals Inc. 10% Owner Buy 100.0 +1,387,283 40.68% ✗ $12M
Apr 13, 2020 Apr 13, 2020 Keros Therapeutics, Inc. Director Buy 100.0 +375,200 50.39% ✗ $6M